
Join to view full profile
1 Medical Center DriveLebanon, NH 03756
Phone+1 603-653-6181
Dr. Alewine is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
University of Maryland School of MedicineClass of 2008
Clinical Trials
Publications & Presentations
PubMed
- Basal Marker ΔNp63α Is Enriched in Pancreatic Cancer Metastases but Not in Primary Tumors Post-Chemotherapy.Daniel H Ryan, Yuuki Ohara, Michael J Kruhlak, Xianyu Zhang, Miao Lin
Cancer Medicine. 2026-10-01 - 4 citationsEfficacy of Bidirectional Paclitaxel plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single Institution Analysis of Two Phase II Clinical Trials.Amber F Gallanis, Shruthi R Perati, Stephanie N Canady, Monica Epstein, Nancy Moore
Annals of Surgical Oncology. 2026-05-01 - ASO Visual Abstract: Efficacy of Bidirectional Paclitaxel Plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single-Institution Analysis of Two Phase II C...Amber F Gallanis, Shruthi R Perati, Stephanie N Canady, Monica Epstein, Nancy Moore
Annals of Surgical Oncology. 2026-05-01
Press Mentions
Can Chemo Help KRAS Inhibitors Work Better Against Pancreatic Cancer?August 20th, 2024
New Drug Shows Promise Against Pancreatic Cancer and Breast CancerFebruary 12th, 2021
Drug Is Promising Against Pancreatic and Breast CancersFebruary 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: